278 related articles for article (PubMed ID: 24966975)
21. Endolymphatic sac tumor associated with a von Hippel-Lindau disease patient: an immunohistochemical study.
Horiguchi H; Sano T; Toi H; Kageji T; Hirokawa M; Nagahiro S
Mod Pathol; 2001 Jul; 14(7):727-32. PubMed ID: 11455007
[TBL] [Abstract][Full Text] [Related]
22. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
23. A histopathological connection between a fatal endolymphatic sac tumour and von Hippel-Lindau disease from 1960.
Bellairs JA; Gluth MB
J Laryngol Otol; 2018 Jan; 132(1):75-78. PubMed ID: 28874214
[TBL] [Abstract][Full Text] [Related]
24. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
[TBL] [Abstract][Full Text] [Related]
25. [Endolymphatic sac tumor and von Hippel-Lindau disease. Review of the literature].
de Minteguiaga C; García Ibáñez L; Tran Ba Huy P
Acta Otorrinolaringol Esp; 2002; 53(7):515-20. PubMed ID: 12487074
[TBL] [Abstract][Full Text] [Related]
26. Endolymphatic sac tumors: experience of three cases.
Bastier PL; de Mones E; Marro M; Elkhatib W; Franco-Vidal V; Liguoro D; Darrouzet V
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1551-7. PubMed ID: 23212692
[TBL] [Abstract][Full Text] [Related]
27. Management of von Hippel-Lindau disease-associated CNS lesions.
Wind JJ; Lonser RR
Expert Rev Neurother; 2011 Oct; 11(10):1433-41. PubMed ID: 21955200
[TBL] [Abstract][Full Text] [Related]
28. von Hippel-Lindau syndrome.
Chou A; Toon C; Pickett J; Gill AJ
Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
[TBL] [Abstract][Full Text] [Related]
29. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience.
Bell D; Gidley P; Levine N; Fuller GN
Ann Diagn Pathol; 2011 Apr; 15(2):117-23. PubMed ID: 21167761
[TBL] [Abstract][Full Text] [Related]
30. Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.
Kim HJ; Hagan M; Butman JA; Baggenstos M; Brewer C; Zalewski C; Linehan WM; Lonser RR
Laryngoscope; 2013 Feb; 123(2):477-83. PubMed ID: 23070752
[TBL] [Abstract][Full Text] [Related]
31. Cochlear implantation for hearing loss associated with bilateral endolymphatic sac tumors in von Hippel-Lindau disease.
Jagannathan J; Lonser RR; Stanger RA; Butman JA; Vortmeyer AO; Zalewski CK; Brewer C; Surowicz C; Kim HJ
Otol Neurotol; 2007 Oct; 28(7):927-30. PubMed ID: 17468670
[TBL] [Abstract][Full Text] [Related]
32. [Tumour staged surgery of endolymphatic sac tumors (ELST)].
Schipper J; Maier W; Rosahl S; Berlis A; Laszig R
Laryngorhinootologie; 2004 Aug; 83(8):493-500. PubMed ID: 15316888
[TBL] [Abstract][Full Text] [Related]
33. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
Jester R; Znoyko I; Garnovskaya M; Rozier JN; Kegl R; Patel S; Tran T; Abedalthagafi M; Horbinski CM; Richardson M; Wolff DJ; Lapadat R; Moore W; Rodriguez FJ; Mull J; Olar A
Acta Neuropathol Commun; 2018 Oct; 6(1):107. PubMed ID: 30340515
[TBL] [Abstract][Full Text] [Related]
34. Hearing preservation surgery for small endolymphatic sac tumors in patients with von Hippel-Lindau syndrome.
Megerian CA; Haynes DS; Poe DS; Choo DI; Keriakas TJ; Glasscock ME
Otol Neurotol; 2002 May; 23(3):378-87. PubMed ID: 11981399
[TBL] [Abstract][Full Text] [Related]
35. Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.
Zanoletti E; Girasoli L; Borsetto D; Opocher G; Mazzoni A; Martini A
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):423-429. PubMed ID: 29165437
[TBL] [Abstract][Full Text] [Related]
36. Papillary adenoma of endolymphatic sac origin: a temporal bone tumor in von Hippel-Lindau disease. Case report.
Ouallet JC; Marsot-Dupuch K; Van Effenterre R; Kujas M; Tubiana JM
J Neurosurg; 1997 Sep; 87(3):445-9. PubMed ID: 9285613
[TBL] [Abstract][Full Text] [Related]
37. Deafness due to bilateral endolymphatic sac tumours in a case of von Hippel-Lindau syndrome.
Kempermann G; Neumann HP; Scheremet R; Volk B; Mann W; Gilsbach J; Laszig R
J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):318-20. PubMed ID: 8795608
[TBL] [Abstract][Full Text] [Related]
38. Neurologic manifestations of von Hippel-Lindau disease.
Butman JA; Linehan WM; Lonser RR
JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
[TBL] [Abstract][Full Text] [Related]
39. "Endolymphatic sac tumour": A case report with review of literature.
Rajeshwari B; Shanmugam S; Sadiya N; Mitra G; Chendilnathan B
Indian J Pathol Microbiol; 2019; 62(4):608-610. PubMed ID: 31611452
[TBL] [Abstract][Full Text] [Related]
40. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
